Podcasts about Pancreas

John, 40, shares his family's deep autoimmune history and his 11-year-old daughter's new T1D diagnosis, plus his personal experience with GLP-1 meds. Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Tandem Mobi ** twiist AID System Drink AG1.com/Juicebox Use code JUICEBOX to save 40% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

After far too long, Mark Popeney returns to discuss Brian Wilson, The Beach Boys and the amazing song Pancreas! Learn more about your ad choices. Visit megaphone.fm/adchoices

The pancreas is a complex organ, but some key biomarkers can assess its health. The pancreas is both an exocrine organ (meaning it produces enzymes) and an exocrine organ (meaning it secretes hormones). It's a key component of your metabolic health and therefore your overall health. Dr. Robert Lustig and Mike Haney discuss key pancreatic blood work to get checked, the differences between diabetes types and what causes them, what insulin resistance is, how to restore mitochondrial function through diet and lifestyle changes, and more.Get a Free Guide to Understanding Your Lab Results: ⁠⁠https://levels.link/wnl⁠⁠Levels helps you see how food affects your health, empowering you with the tools needed to achieve health goals and improve healthspan. Levels Members gain access to the Levels app and continuous glucose monitors (CGMs), providing real-time feedback on how diet and lifestyle choices impact your metabolic health.Look for new shows every month on A Whole New Level, where we have in-depth conversations with thought leaders about metabolic health.

7/10/2025 | Pancreas

In the corner of the ICU, on multiple pressors, distended, oliguric, and intubated you'll find the necrotizing pancreatitis patient. Sounds intimidating, but with the persistence, patience, and the proper care these patients can make it! In this episode from the HPB team at Behind the Knife listen in as we discuss the Step-Up approach, when to surgically intervene, various approaches to pancreatic Necrosectomy, and additional aspects of the multidisciplinary care required for the successful treatment of necrotizing pancreatitis.  Hosts Anish J. Jain MD (@anishjayjain) is a current PGY3 General Surgery Resident at Stanford University and a former T32 Research Fellow at the University of Texas MD Anderson Cancer Center. Jon M. Harrison is a 2nd year HPB Surgery Fellow at Stanford University. He will be joining as faculty at the Massachusetts General Hospital in Boston, MA at the conclusion of his fellowship in July 2024.    Learning Objectives ·      Develop an understanding of the severity of necrotizing pancreatitis and the proper indications to surgical intervene on this often-tenuous patients.  ·      Develop an understanding of the Step-Up approach and key aspects (reimaging, clinical status, physiologic status, etc.) that determine when to “step-up” treatment for patients with necrotizing pancreatitis. ·      Develop an understanding of long term sequalae and complications associated with necrotizing pancreatitis and operative management ·      Develop an understanding of multidisciplinary care and long-term follow-up necessary for adequate treatment of patients suffering from necrotizing pancreatitis. Suggested Reading Maurer LR, Fagenholz PJ. Contemporary Surgical Management of Pancreatic Necrosis. JAMA Surg. 2023;158(1):81–88. doi:10.1001/jamasurg.2022.5695 https://pubmed.ncbi.nlm.nih.gov/36383374/ Harrison JM, Day H, Arnow K, Ngongoni RF, Joseph A, Aldridge T, Wheeler KJ, DeLong JC, Bergquist JR, Worth PJ, Dua MM, Friedland S, Park W, Eldika S, Hwang JH, Visser BC. What's Behind it all: A Retrospective Cohort Study of Retrogastric Pancreatic Necrosis Management. Ann Surg. 2024 Sep 3. doi: 10.1097/SLA.0000000000006521. https://pubmed.ncbi.nlm.nih.gov/39225420/ Harrison JM, Visser BC. Not Dead Yet: Managing the Abdominal Catastrophe in Necrotizing Pancreatitis. Pancreas. 2025 May 20. doi: 10.1097/MPA.0000000000002512. https://pubmed.ncbi.nlm.nih.gov/40388698/ Harrison JM, Li AY, Sceats LA, Bergquist JR, Dua MM, Visser BC. Two-Port Minimally Invasive Nephrolaparoscopic Retroperitoneal Debridement for Pancreatic Necrosis. J Am Coll Surg. 2024 Dec 1;239(6):e7-e12. doi: 10.1097/XCS.0000000000001152. https://pubmed.ncbi.nlm.nih.gov/39051721/ van Santvoort HC, Besselink MG, Bakker OJ, Hofker HS, Boermeester MA, Dejong CH, van Goor H, Schaapherder AF, van Eijck CH, Bollen TL, van Ramshorst B, Nieuwenhuijs VB, Timmer R, Laméris JS, Kruyt PM, Manusama ER, van der Harst E, van der Schelling GP, Karsten T, Hesselink EJ, van Laarhoven CJ, Rosman C, Bosscha K, de Wit RJ, Houdijk AP, van Leeuwen MS, Buskens E, Gooszen HG; Dutch Pancreatitis Study Group. A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med. 2010 Apr 22;362(16):1491-502. doi: 10.1056/NEJMoa0908821. https://pubmed.ncbi.nlm.nih.gov/20410514/ Bang JY, Arnoletti JP, Holt BA, Sutton B, Hasan MK, Navaneethan U, Feranec N, Wilcox CM, Tharian B, Hawes RH, Varadarajulu S. An Endoscopic Transluminal Approach, Compared With Minimally Invasive Surgery, Reduces Complications and Costs for Patients With Necrotizing Pancreatitis. Gastroenterology. 2019 Mar;156(4):1027-1040.e3. doi: 10.1053/j.gastro.2018.11.031. https://pubmed.ncbi.nlm.nih.gov/30452918/ Zyromski NJ, Nakeeb A, House MG, Jester AL. Transgastric Pancreatic Necrosectomy: How I Do It. J Gastrointest Surg. 2016 Feb;20(2):445-9. doi: 10.1007/s11605-015-3058-y. https://pubmed.ncbi.nlm.nih.gov/26691148/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

This week on We Are T1D, Mike and Jack welcome a very special guest — actor and Waterloo Road star Ollie Rhodes — for a refreshingly honest, funny, and relatable chat about life with Type 1 diabetes.From spotting the first signs of T1D during a football match to navigating acting roles with an insulin pump tucked under his costume, Ollie shares it all: the highs, the hypos, and the hilarious misconceptions (yes, someone thought he was tagged by police because of his pod!).Whether you're newly diagnosed or a long-time warrior, this episode is a reminder that while diabetes never takes a day off, it also brings unlikely friendships, hard-earned wisdom, and a few free snacks along the way.In this episode:⚽ Ollie's diagnosis story – including the football match moment that changed everything

Episode: 3065 Victor and Eva Saxl: Love, War and Homemade Insulin.  Today, love, war and insulin.

In this monolog, Vijay talks about a novel discovery highlighting the role of Innate lymphoid cells in regulation of blood glucose in fasting condition. This is the second part in the 2-part series.

In this multipart monolog, Vijay talks about a novel discovery highlighting the role of Innate lymphoid cells in regulation of blood glucose in fasting condition. This is the first part to the 2-part series.

BUFFALO, NY — June 17, 2025 — A new #research paper was #published in Aging (Aging-US) Volume 17, Issue 5, on May 1, 2025, titled “Oxytocin modulates insulin and GLP-1 secretion in pancreatic islets.” In this study, scientists from Fukushima Medical University School of Medicine investigated how the hormone oxytocin (Oxt) influences insulin levels by acting on specific cells in the pancreas. The team led by first author Kasumi Hattori and corresponding authors Kenju Shimomura and Yuko Maejima discovered that oxytocin may indirectly increase insulin secretion by triggering another hormone, GLP-1, from within the pancreas. This finding could lead to new strategies for improving blood sugar control in people with diabetes. Oxytocin is commonly known for its roles in childbirth and social bonding, but scientists have also been exploring its effects on metabolism. While previous studies offered mixed results about whether oxytocin raises or lowers blood sugar, this research brings new clarity. The study focused on oxytocin's impact on insulin and a hormone called GLP-1, which helps regulate insulin production. Researchers tested this by using mice with and without oxytocin receptors and found that oxytocin's ability to raise insulin levels depended on the presence of these receptors and high blood sugar conditions. Researchers found that oxytocin stimulates the release of “intra-islet GLP-1,” a form of GLP-1 produced inside the pancreas rather than the intestine. In the pancreas, insulin is produced by beta cells, while alpha cells produce glucagon, a hormone that raises blood sugar. But recent research, including this study, has shown that alpha cells can also release GLP-1, which in turn helps beta cells secrete insulin. Oxytocin appears to increase this internal GLP-1 release, especially when blood sugar levels are high, thereby leading to insulin release in a natural and targeted way. In this study researchers were also able to detect the difference between oxytocin's effect on blood sugar and its effect on insulin. They observed that right after oxytocin was given, blood sugar levels rose in all mice—even in those that lacked oxytocin receptors. However, only the mice with working oxytocin receptors showed a later increase in insulin. This suggests that oxytocin may trigger insulin production through a separate, receptor-dependent pathway involving the hormone GLP-1. "WT mice showed a significant increase in insulin levels at 15-min, while OxtR KO mice did not." This indirect action—oxytocin triggering alpha cells to release GLP-1, which then acts on beta cells—may represent a novel mechanism for controlling insulin release. It also explains why oxytocin does not increase insulin in low-glucose conditions, making it a potentially safer option for regulating blood sugar. As treatments for type 2 diabetes increasingly focus on GLP-1–based drugs, this study opens the door to using oxytocin or similar compounds to naturally enhance the body's own insulin-producing system. With further research, this mechanism could help develop new therapies that better mimic the body's natural glucose control, particularly beneficial for older adults with diabetes. DOI - https://doi.org/10.18632/aging.206244 Corresponding authors - Kenju Shimomura - shimomur@fmu.ac.jp, and Yuko Maejima - maejimay@fmu.ac.jp Video short - https://www.youtube.com/watch?v=C0K6uDX4z8U To learn more about the journal, please visit our website at https://www.Aging-US.com​​ and connect with us on social media at: Facebook - https://www.facebook.com/AgingUS/ X - https://twitter.com/AgingJrnl Instagram - https://www.instagram.com/agingjrnl/ YouTube - https://www.youtube.com/@AgingJournal LinkedIn - https://www.linkedin.com/company/aging/ Bluesky - https://bsky.app/profile/aging-us.bsky.social Pinterest - https://www.pinterest.com/AgingUS/ Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

When complications like chronic kidney disease and Type 1 diabetes intersect, it can feel overwhelming. In this episode, Dr. Steve Edelman sits down with Kristen Hohmann, a Type 1 diabetic who underwent both kidney and pancreas transplants, to explore her journey of managing diabetes, overcoming kidney failure, and pursuing the life-changing decision to undergo a dual organ transplant. Kristen shares the emotional, physical, and mental challenges she faced along the way, offering valuable insights into the transplant process and the importance of self-advocacy.Key Topics:Kristen's diagnosis of Type 1 diabetes and the progression to kidney failureThe emotional toll of needing a kidney transplantHow Kristen researched and decided on a kidney and pancreas transplantThe transplant process: Waiting for a donor and the realities of the surgeryThe challenges of recovery and life after receiving a new kidney and pancreasHow self-advocacy played a crucial role in Kristen's journeyThe importance of a multidisciplinary approach to diabetes care and transplant managementInsights into life after diabetes and the impact of the transplant on Kristen's healthAmerican Diabetes Association (ADA): www.diabetes.orgNational Kidney Foundation: www.kidney.orgMayo Clinic Transplant Services: www.mayoclinic.org ★ Support this podcast ★

In this episode I have shared my experience with an AI agent I have created regarding a Simulated case of Carcinoma head of the Pancreas. It was highly interactive and educational. I documented the whole episode as a pdf and the same I am giving as an audio file.

Lo studio italiano CASSANDRA di fase 3, randomizzato, multicentrico, appena presentato al Congresso annuale dell’American Society of Clinical Oncology (ASCO), a Chicago, e totalmente finanziato da associazioni di pazienti, ha coinvolto 17 ospedali in Italia, focalizzandosi sul trattamento preoperatorio dei pazienti con tumore del pancreas non metastatico, e ottenendo un miglioramento dei risultati rispetto all’attuale standard terapeutico. A Obiettivo Salute il commento del prof. Michele Reni, primario delle Unità Operative di Oncologia e Day Hospital Oncologico, direttore del programma strategico di coordinamento clinico del Pancreas Center all'IRCCS Ospedale San Raffaele, associato di Oncologia dell’Università Vita-Salute San Raffaele, ideatore e coordinatore dello studio.

In this specialty podcast, Dr. Alissar El Chediak is joined by Dr. Jon Odorico and Dr. Ron Parsons to discuss the current state of pancreas transplantation, identify barriers and strategies for referral and candidate selection, and discuss solutions to address the decline in procedures. Alissar El Chediak, MD is a transplant nephrologist at UT Southwestern Medical Center. Jon Odorico, MD is a transplant surgeon at the University of Wisconsin. Ron Parsons, MD is a transplant surgeon at the University of Pennsylvania.   References: Generating strategies for a national comeback in pancreas transplantation: A Delphi survey and US conference report

Yi-Chun Chen is taking a close-up look at some of the body's hardest-working cells — the ones often processing an overabundance of modern-day food and nutrients. “From an evolutionary point of view, our cells are not designed to deal with that,” said Dr. Chen, who joined the department of Anatomy, Physiology, and Pharmacology at the University of Saskatchewan last year as an assistant professor. She said our bodies are pushed into churning out large amounts of insulin rapidly after snacks and meals, “which makes the beta cells work extra hard.” Raised in Taiwan and inspired by her grandfather—a retired elementary school science teacher—Chen's fascination with biology first led her to work as a medical laboratory technologist, then to the world of cellular research. Using both rodent and human models, Chen is studying pancreatic beta cells: the way they process peptide hormones like insulin and how their behaviour and function is affected by an excess of nutrients. Using high-resolution imaging, she and her team are examining how both humans and mice synthesize, process, and clear peptide hormones. “There are a lot of things we still don't know about peptide hormones, not just in the pancreas, but in the brain, in the gut,” she said. “Those are fascinating.” Last year, Chen was the recipient of a Canadian Institutes of Health Research Early Career Transition Award. After moving from UBC to Saskatchewan, Dr. Chen said she's thankful to see so much support already from her established and mid-career prairie colleagues. “They can mentor us and guide us, and we also have a group of five or six young scientists,” she said. “I can envision myself working on many, many interesting projects with them.” Her goal today is to identify biomarkers that could predict diabetes far earlier. She hopes to develop biochemical assays that measure proinsulin levels to serve as an early warning system. This could enable interventions months or even years before a traditional diagnosis based on blood glucose levels. “We want to be able to predict the development of, for example, type 1 or type 2 diabetes before they are diagnosed,” said Chen. In the long term, Chen envisions both preventative strategies and regenerative therapies to fight diabetes. Stem cell-derived beta cells may be a future solution, she said. “We are making really good progress in Canada, actually. We have clinical trials. We're putting the stem cell–derived beta cells into patients with type 1 diabetes.” She hopes this will one day reduce the need for constant insulin injections, even helping curb  obesity. “Don't give up,” Chen said. “We are passionate and we want to work on many, many things.” “If you like it, keep going.”

In this episode of Bowel Sounds, hosts Dr. Jenn Lee and Dr. Peter Lu  talk with Dr. Nishant Patel, pediatric gastroenterologist at Orlando Health Arnold Palmer Hospital for Children, about the diagnosis and evaluation of exocrine pancreatic insufficiency (EPI) in children. Learning objectivesRecognize the varied clinical presentations of exocrine pancreatic insufficiency (EPI)Compare the utility, advantages, and limitations of diagnostic tools for EPIApply evidence-based protocols for performing and interpreting ePFTEndoscopic Pancreatic Function Testing (ePFT) in Children: A Position Paper From the NASPGHAN Pancreas CommitteeSupport the showThis episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

Part 2 of the replay of episode #41: A Pancreas Transplant: Last Chance of Survival for Brandon Mouw. As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

We'd love to hear from you! Please send us a Text Message!So much of life I take for grantedI wake each day to face the same routineThe colors often runIn shades of monotone and greyAnd the days melt togetherIn a frivolous clichéBut occasionally, now and thenOnce or twice when the moon is blueI'll be walking across a roomAnd a thought will comeFrom out of nowhereSo stunningAs to make meStop in my tracksTo consider the infiniteThe mysteries of lifeTheater of the Imagination is brought to you by Watchfire Music Updated Watchfire Music Commercial To access all of the episodes in our podcast, please subscribe to Watchfire Music's Theater Of The Imagination Subscription Series. Unlock all of the episodes and experience so much more! Learn More here: https://bit.ly/theater-of-the-imagination-info Or, if you're ready to subscribe, subscribe here: https://bit.ly/subscribe-to-theater-of-the-imagination We'd love to hear from you! Please send us a Text Message!

The risk for many chronic diseases is directly linked to metabolic changes in the body and loss of muscle mass often associated with aging. In this excerpt, Dr. Natalie Marshall focuses on the role that muscles play in the body. Series: "Osher WISE: Well-being and Integrative Science for Everyone" [Health and Medicine] [Show ID: 40685]

The risk for many chronic diseases is directly linked to metabolic changes in the body and loss of muscle mass often associated with aging. In this excerpt, Dr. Natalie Marshall focuses on the role that muscles play in the body. Series: "Osher WISE: Well-being and Integrative Science for Everyone" [Health and Medicine] [Show ID: 40685]

The risk for many chronic diseases is directly linked to metabolic changes in the body and loss of muscle mass often associated with aging. In this excerpt, Dr. Natalie Marshall focuses on the role that muscles play in the body. Series: "Osher WISE: Well-being and Integrative Science for Everyone" [Health and Medicine] [Show ID: 40685]

The risk for many chronic diseases is directly linked to metabolic changes in the body and loss of muscle mass often associated with aging. In this excerpt, Dr. Natalie Marshall focuses on the role that muscles play in the body. Series: "Osher WISE: Well-being and Integrative Science for Everyone" [Health and Medicine] [Show ID: 40685]

The risk for many chronic diseases is directly linked to metabolic changes in the body and loss of muscle mass often associated with aging. In this excerpt, Dr. Natalie Marshall focuses on the role that muscles play in the body. Series: "Osher WISE: Well-being and Integrative Science for Everyone" [Health and Medicine] [Show ID: 40685]

A replay of episode #41: A Pancreas Transplant: Last Chance of Survival for Brandon Mouw. As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

Get a Skratch Labs sample pack on us!Support us on Patreon!Thanks, Janji! Use code YDS for 10% off!Are CGMs the new step counter—or a $200 anxiety machine? In this episode, Zoë and Kylee discuss blood sugar basics, why fluctuations are normal, and how endurance athletes can make sense of numbers like A1C and glucose spikes without spiraling into diet culture doom.We break down:Why blood sugar goes up (and why that's not a bad thing)What CGMs actually tell you (and what they don't)How stress, sleep, and undereating mess with your blood sugarCommon myths around “spiking,” bonking, and insulinWhether high-carb fueling is risky or actually the pointWhy your oatmeal might be lying to youHow to build more satisfying meals and snacks—without tracking every gramAnd of course, the history of medical professionals tasting pee, becasue, of course.We also unpack the growing trend of CGM use in healthy athletes, the risks of over-optimization, and what your doctor might be missing when they say “pre-diabetic.”

Dr. Gabriel Cousens shares groundbreaking insights on curing diabetes through holistic approaches. Discover how lifestyle changes and nutrition can reverse diabetes naturally. #DiabetesCure #HolisticHealth #Nutrition

Host: Darryl S. Chutka, M.D. Guests: Nitin N. Katariya, M.D., and Lavanya Kodali, M.B.B.S., M.D. At this time, about 11% of the population in the U.S. has diabetes.  This represents nearly 40 million people. And this number is increasing, not only in the U.S. but around the world. Although we have more medical options now than ever before for managing diabetes, the treatment is less than optimal. Another option is a pancreas transplant. What's the status of pancreatic transplantation? Who's a candidate for the procedure? How effective is it and what does the future hold for the procedure?  The topic for this podcast is “Pancreas Transplantation” and I'll be discussing these questions with Nitin N. Katariya, M.D., a transplant surgeon and Lavanya Kodali, M.B.B.S., M.D., a nephrologist and specialist in renal transplant, both from the Arizona campus of the Mayo Clinic. Learn more about this Transplant Series:  Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development Connect with Mayo Clinic's Transplant Center online at https://mayoclinic.org/transplant or on Twitter @MayoTransplant To learn more and register to be an organ donor please visit https://careinfo.mayoclinic.org/organ-donation. Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development

4/3/2025 | Pancreas

In this episode of Reclaim Your Rise, Abby is back for a heartfelt conversation with the Smith family. We met Tyler and Callie after their son Wally's T1D diagnosis at age 4. They came to us feeling lost trying to function as their child's pancreas and needing more support than they were getting from their doctor. While Callie and Tyler's experience will especially resonate with other parents, this episode is for everyone who wants to understand what T1D parents are really going through. Quick Takeaways:Importance of knowing the signs & symptoms of type 1 diabetesThe mental & physical toll a T1D diagnosis takes on the entire family How family dynamics play a significant role in managing & finding a balance in parenting roles Maintaining your relationship as parents while still caring for your T1D child The need for better communication with healthcare providers about care expectationsTimestamps:[01:45] Meet the Smith Family [02:30] Wally's diagnosis [07:07] Emotions post-diagnosis & learning their new life [09:24] The standard of diabetes care [11:00] Deciding they needed more support [15:27] “You can't pour from an empty cup.” [16:43] Balancing parenting roles & dynamics: Knowing when to ‘tap out' [18:00] Self care: The key to family well being [20:00] Finding Risely [27:05] “We were sick of just getting a pat on the back and a gold star, every time we went to the endo…we weren't getting what we needed.” [29:40] Words of encouragement for T1D parents What to do now: Follow me @lauren_bongiorno and @riselyhealth on Instagram to stay in the loop when new episodes drop.Apply for coaching and talk to our team so you can reclaim the life you deserve. 

Dr Charlie Andrews talks to Dr John Leeds. John Leeds is a Consultant Pancreaticobiliary Physician and Endoscopist based at the Freeman Hospital in Newcastle and an Honorary Clinical Senior Lecturer based in the Population Health Sciences Institute at Newcastle University. He is involved in research in pancreaticobiliary disorders including benign and malignant conditions as well as outcomes from therapeutic/advanced endoscopy.John is a member of the British Society of Gastroenterology and Pancreatic Society of Great Britain and Ireland. He serves on the endoscopy and Pancreas committees for BSG and is the website lead for PSGBI.He is also a founder member of the BSG Pancreas Clinical Research Group which is coordinating research for the society.Key Learnings from this episode:Challenges in Early Detection of Pancreatic Cancer • Pancreatic cancer is often diagnosed at an advanced stage due to the deep location of the pancreas and the lack of early symptoms. • Tumors in the body and tail of the pancreas can grow significantly before causing symptoms, often invading major arteries or veins, making them inoperable. • Tumors in the head of the pancreas may present earlier due to bile duct obstruction, leading to jaundice, but even these are often detected late. Early Symptoms and Red Flags • Early symptoms are vague or absent, making early diagnosis difficult. • Possible early indicators include: • Weight loss (often a sign of advanced disease). • New-onset diabetes, particularly in individuals with a normal BMI or without typical risk factors for type 2 diabetes. • Jaundice, which is a significant red flag and often indicates a serious underlying condition. • Classic signs like painless jaundice and Courvoisier's sign (palpable gallbladder) are important but not always present. Limitations of Current Screening Methods • There is no reliable biomarker or screening test for pancreatic cancer: • CA19-9 is not suitable as a screening tool due to its lack of specificity (elevated in other conditions). • Imaging techniques like CT scans or MRIs are used but have limitations, including incidental findings that may lead to unnecessary anxiety (“scanxiety”) and over-investigation. • Screening is currently limited to high-risk groups, such as those with familial pancreatic cancer syndromes or hereditary pancreatitis. High-Risk Groups for Screening • Familial pancreatic cancer accounts for less than 10% of cases. Criteria for screening include: • Multiple family members with pancreatic cancer, especially diagnosed under age 50–60. • Genetic syndromes like BRCA mutations, familial adenomatous polyposis (FAP), and Peutz-Jeghers syndrome. • Hereditary pancreatitis patients have an increased risk but are harder to screen due to pre-existing pancreatic abnormalities. Emerging Research and Future Directions • Studies are exploring potential biomarkers, such as microbiome signatures in the pancreas, which might help identify high-risk individuals in the future. • Trials like the EuroPAC study focus on surveillance protocols for high-risk individuals using imaging techniques like MRI or endoscopic ultrasound. • Research into new-onset diabetes as a potential marker for pancreatic cancer is ongoing but currently has a low yield due to the high prevalence of type 2 diabetes unrelated to malignancy. Considerations for Screening and Surveillance • Screening should be carefully targeted to avoid over-diagnosis and unnecessary investigations. • The psychological impact of screening (e.g., anxiety from incidental findings) must be considered. • Smoking cessation is emphasized as smoking is a significant risk factor for pancreatic cancer. Advances in Treatment Approaches • PET-CT scans are increasingly used to detect systemic disease that might not be evident on standard CT scans. • Neoadjuvant treatments (therapy before surgery) are being... Chapters (00:00:00) - Ingest(00:00:53) - Pancreatic Cancer(00:04:03) - New diabetes and pancreatic cancer(00:08:01) - Pancreatic Cancer: Screening(00:15:42) - Determining breast cancer early is hard(00:16:03) - Pulmonary neuroendocrine tumors of the pancreas(00:22:26) - Pancreatic cancer 20, Management(00:29:00) - Pancreatic cancer, management principles(00:33:48) - Primary Care Take Home: Pancreas, pain(00:40:29) - Primary Care: Pancreas Cancer Episode 2

Dr. Boros holds a Doctor of Medicine (M. D.) degree from the Albert Szent-Györgyi School of Medicine, Szeged, Hungary and is a retired Professor of Pediatrics, Endocrinology and Metabolism of the University of California Los Angeles (UCLA) School of Medicine. Dr. Boros is the co-inventor of the stable isotope-based dynamic metabolic profiling (SIDMAP) technology, which is a functional biochemistry tool used for detailed biochemical and deutenomics related drug testing, library screening, lead optimization and in vitro and in vivo phenotype profiling. The core technology involves studying natural and disease/drug induced variations in stable non-radiating stable 13C (carbon) and 2H (deuterium) isotope distribution patterns and cross talk among metabolites in living systems. He also established mitochondrial quantum vacuum as the prime driving force of all life related energy producing biochemical events. These occur via the quantum destabilization of hydrogen ions, i. e. protons, in structured water of mitochondrial nano-confinements that are compromised by deuterium; hence the regulation of deuterium (deutenomics, human deutenome project) is a critical process to maintain health and longevity.Dr. Boros trained as a house staff in his medical school in gastroenterology after receiving a research training fellowship from the Hungarian Academy of Sciences.  Dr. Boros was a visiting Scholar at the Essen School of Medicine in Germany and also worked as a Research Scientist at the Ohio State University, Department of Surgery.  Dr. Boros is the recipient of the C. Williams Hall Outstanding Publication Award from the Academy of Surgical Research of the United States (1997), the Richard E. Weitzman Memorial Research Award from the University of California (2001), the Excellence in Clinical Research Award from the General Clinical Research Center at the Harbor-UCLA Medical Center (2004) and Public Health Impact Investigator Award of the United States Food and Drug Administration (2011).  Dr. Boros serves as an associate editor for the journals Springer Nature- Scientific Reports, Medicine, Pancreas, Molecules and Metabolomics.SHOWNOTES:

In this episode of SurgOnc Today®, Dr. Patricio Polanco, from the University of Texas Southwestern and Vice-chair of the SSO HPB disease site working group, and Dr. Sandra DiBrito, from Albany Medical College and member of the HPB disease site working group, are joined by Dr. Marc Besselink, of Amsterdam University Medical Center, and Dr. Amer Zureikat, of University of Pittsburgh. This is the second episode in our Minimally Invasive Techniques in Hepatobiliary Surgery Series. We will focus today on minimally invasive pancreas surgery.

Dr Charlie Andrews talks to Dr John Leeds. John Leeds is a Consultant Pancreaticobiliary Physician and Endoscopist based at the Freeman Hospital in Newcastle and an Honorary Clinical Senior Lecturer based in the Population Health Sciences Institute at Newcastle University. He is involved in research in pancreaticobiliary disorders including benign and malignant conditions as well as outcomes from therapeutic/advanced endoscopy.John is a member of the British Society of Gastroenterology and Pancreatic Society of Great Britain and Ireland. He serves on the endoscopy and Pancreas committees for BSG and is the website lead for PSGBI.He is also a founder member of the BSG Pancreas Clinical Research Group which is coordinating research for the society. Chapters (00:00:01) - Ingest: pancreatic lesions(00:01:09) - Pancreas(00:05:39) - Chronic Pancreas disease, early signs and symptoms(00:11:54) - Pulmonary pancreatitis, diagnosis and management(00:17:52) - Diarrhea, weight loss(00:18:29) - Pancreatic disease, ultrasound and the best treatment(00:23:49) - Pancreatitis, chronic pancreatitis in primary care(00:26:19) - Pancreatitis 20, Surgery or drainage?(00:32:24) - Pancreatic Exocrine Insufficiency(00:38:05) - Pulmonary dysrhythmias, management tips(00:43:46) - PPI for cystic fibrosis patients 8,(00:46:16) - Pancreatic insufficiency 20, Detection and treatment(00:49:57) - Pancreatic cysts(00:55:32) - Choosing the right cyst for surgery(00:57:20) - autoimmune pancreatitis, presentation and treatment(01:03:34) - Pancreatic cancer: diagnosis and treatment(01:06:14) - Pancreatitis, part 1, unboxing

Yeah, that little thing is pretty important.  So, don't drink too much Nuka Victory Cola from your giant theater soda cup.  Your Pancreas will thank you. Episode art remixed from: Photo by Tima Miroshnichenko: https://www.pexels.com/photo/medical-people-looking-at-an-image-on-computer-monitors-6235052/

3/4/2025 | Pancreas

3/4/2025 | Pancreas

In this episode of SurgOnc Today®, Dr. Rebecca Snyder, from the UT MD Anderson Cancer Center, and Dr. Akhil Chawla, from Northwestern University, both members of the HPB disease site working group, are joined by Dr. Cristina Ferrone, from Cedars Sinai Medical Center, and Dr. Steven Gallinger, from the University of Toronto. We will discuss the details, similarities, and differences of their respective clinical trials for neoadjuvant therapy for pancreatic adenocarcinoma, ALLIANCE A021806, and NeoPancONE.   References/Resources: ALLIANCE A021806 NeoPancONE

2025 is set to bring major advancements in diabetes technology, from AI-driven CGMs to new insulin pumps like Medtronic's upcoming 8-series and patch pump, and the Tidepool Loop-based twiist pump. I spoke with Gary Scheiner, a CDCES and author of Think Like a Pancreas, to break down what these innovations mean for diabetes management.   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US only)   Read our Blog + Join the Newsletter    Support Diabetech on Patreon  | Diabetech Community Discord   Follow me here: Instagram | Tik Tok | YouTube | Facebook   Gary's Practice Gary's Book Think Like a Pancreas   Watch the Podcast on Youtube   DISCLAIMERS: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.   *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Send us a message!In this episode we will be covering Facebook Live Questions 1/6-1/12/24  from Dana's free Facebook Group Registered Dietitian Exam Study Group with Dana RD!Get the free RD Exam Prep Masterclass here. Looking for additional tutoring service? Visit my website! Shop all recorded courses at https://danajfryernutritiontutoring.teachable.comJoin the RD Exam Prep Mastery Program for access to the Situational Practice Questions, Vocab Classes, Wed 8pest Group tutoring , study guides and a new trouble area video each week!Free Downloads: danajfryernutritiontutoring.teachable.com/p/my-downloadable-462494

In this episode, hosts Drs. Temara Hajjat and Jenn Lee talk to Dr. David Vitale about EUS and ERCP indications in patients with acute pancreatitis and pancreatitis complications. Dr. Vitale is a pediatric gastroenterologist, the director of the interventional endoscopy center at Cincinnati Children's Hospital and Medical Center, and an Assistant Professor at the University of Cincinnati School of Medicine.  Learning Objectives:Understanding the indications of ERCP and EUS in acute pancreatitis Understand the indications of ERCP and EUS in pancreatitis complications Recognize the possible risks of EUS and ECRP in childrenSupport the showThis episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

In this episode, host Courtney Allison discusses the latest studies on the health risks associated with alcohol use with Dr. Robert Brown, chief of Gastroenterology and Hepatology at NewYork-Presbyterian and Weill Cornell Medicine. They discuss how alcohol affects various organs, including your liver, heart, and brain, as well as its link to several cancers. Dr. Brown discusses the cultural perception of alcohol, the current guidelines around safe drinking limits, and how binge drinking harms the body. 

Support document: https://drive.google.com/file/d/120GhHfWDm3y0hviEZ_trieHu0K0hZQaF/view?usp=drive_link   Find out more about Trinity Health Hub at https://trinityhealthhub.com/.

This week we discuss Abdominal adhesions.  These are bands of scar tissue that form between abdominal tissues and organs. Like the name suggests, the tissue can cause your organs to “adhere,” or stick together. Adhesions commonly form after abdominal surgery. Typically, you don't need treatment unless they cause a complication, like a small bowel obstruction. Abdominal adhesions are bands of scar tissue that form between the organs in your belly and pelvis. Mainly, they form between loops of your small intestine. They can also form between an organ and the wall of your abdominal cavity. Your abdominal cavity contains your: Digestive system, including your stomach and intestines. Female reproductive organs. Kidneys and adrenal glands. Liver. Pancreas. Spleen. Adhesions occur when there's injury or inflammation in your abdomen. They can even form from normal handling during surgery. In fact, they're most common after abdominal surgery. As a natural part of healing, scar tissue forms that can cause tissues to stiffen and stick together (“adhere”). How common are abdominal adhesions? Abdominal adhesions are the most common consequence of having surgery on your abdomen. The majority of people develop adhesions after abdominal surgery. But most people don't need treatment unless they're experiencing symptoms. Adhesions are also the most common cause of a small bowel obstruction. A bowel obstruction is a medical emergency that involves complete or partial blockage in your intestines. (credits Cleveland Clinic)

Behind the Knife ABSITE 2025 – Up-to-date and high yield learning to help you DOMINATE the exam. Don't forget to check out our ABSITE Podcast Companion Book available on Amazon: https://www.amazon.com/Behind-Knife-ABSITE-Podcast-Companion/dp/B0CLDQWZG3/ref=monarch_sidesheet Be sure to check out our brand new free study aid, which includes all 32 review episodes, brief written summaries, high yield images, and flash cards. Simply create an account on our iOS or Android app or on our website and you will find the entire course in your Library. Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Google Play App Store: https://play.google.com/store/apps/details?id=com.btk.app Behind the Knife would like to sincerely thank Medtronic for sponsoring the entire 2025 ABSITE podcast series.  Medtronic has a rich history of supporting surgical education, and we couldn't be happier that they chose to partner with Behind the Knife.  Learn more at https://www.medtronic.com/en-us/index.html If you like the work that Behind the Knife is doing, please leave us a review wherever you listen to podcasts. Visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  

In this episode of The Nutritional Therapy and Wellness Podcast, host Jamie Belz and guest Amanda Jones dive into the fascinating science of blood sugar regulation and how its imbalance impacts the body. They explore how prediabetes and type II diabetes—like many chronic diseases—can often be reversed through strategic diet and lifestyle changes. Discover how achieving balanced blood sugar not only improves energy and vitality but also reduces or eliminates many associated health risks altogether. Amanda Jones is a dedicated instructor with the Nutritional Therapy Association (NTA) and an experienced Functional Nutritional Therapy Practitioner since 2013. In addition to being an FNTP, Amanda holds a master's degree in Human Nutrition and Functional Medicine, a bachelors degree in communications, she's a certified ADAPT Functional Health Coach, a certified GAPS Practitioner and a licensed massage therapist. 2:55 Diabetes, pre-diabetes, insulin - Blood Sugar 101 4:00 Why blood sugar regulation matters 4:45 Blood sugar regulation impacts everything in the entire body - nothing is NOT impacted 5:20 Current statistics for the prevalence of diabetes and pre-diabetes 6:50 Subclinical blood dysregulation - insulin resistance (PRE-PRE-DIABETES) 7:50 Reversing the pathway toward diabetes 10:45 How blood sugar dysregulation impacts the cardiovascular system - cardio-metabolic disease 11:50 Atherosclerosis as a result of blood sugar dysregulation 13:54 Glucose conversion to body fat 14:22 Blood lipids - triglycerides - hyperlipidemia 14:37 Why SUGAR is contributing to obesity rather than fats - as well as circulating lipids - 15:33 How elevated blood sugar drives elevated blood pressure and high blood pressure 16:20 How high insulin levels inhibit the production of nitric oxide levels 18:00 Immune regulation and meta-inflammation - inflammation driven by metabolic problems 19:30 Endocrine disruption from blood sugar dysregulation 21:10 Changes to the nervous system, gut motility, our microbiome, and other things negatively impacted by blood sugar dysregulation 21:40 The stages of dysglycemia 22:37 Insulin is a GOOD hormone! - What it's supposed to do in the body - how it brings sugar into the cells - how energy is produced 24:33 Excess glucose and insulin - reactive hypoglycemia 25:00 The Blood Sugar Rollercoaster - why you're tired at 10:30 AM, 2:30 PM, 8:00 PM 27:02 Insulin resistance 28:12 Fasting Glucose Levels - lab testing - Fasting Insulin Levels 30:20 The progression continues - feeling lethargic, gaining weight, etc. 30:30 Pre-Diabetes diagnosis 31:00 A1C - glycation 31:41 Metabolic Syndrome 32:40 Pancreas damage - insulin injections 33:04 Six small meals per day versus fasting 37:30 Fasting and time-restricted eating 38:09 Our blood sugar is synced with our circadian rhythms 39:58 Walking after meals versus other workouts for blood sugar regulation 41:46 There is HOPE! This doesn't need to be a miserable process. YOU can do it and you can enjoy it! ______________________ Catch Episode 29 to learn quick tips for improving blood sugar regulation for optimal health. Hit Subscribe! Connect with us at www.nutritionaltherapy.com

Movies discussed: Strange Darling, Azrael, Campfire Tales (1997), A Bear in the Woods (short) This time around we find Strange Darling both strange and darling, Azrael proves Samara Weaving is the real deal, and Campfire Tales sparks a faint wisp of nostalgia. Next episodes assignments: MadS Caddo Lake Don't Move Meat Puppet (short) Watch along with us if you like and we'll see you next episode. The post Episode 488 – I Love Your Pancreas appeared first on Horror Show Hot Dog.

Send us a textAbout the guest: Angel Nadal, PhD is a biologist in Spain whose lab studies endocrine disruptors (e.g. microplastics), hormones (estrogen, insulin), and the endocrine functions of the pancreas in health & disease.Episode summary: Nick and Dr. Nadal discuss: endocrine biology of the pancreas; insulin and estrogen signaling in the pancreas; BPA, microplastics, and other xenoestrogens; pregnancy & fetal development; effects of hormone disruptors in males vs. females; and more.Related episodes:M&M 145: Epigenetics, Hormones, Endocrine Disruptors, Microplastics, Xenoestrogens, Obesogens & Obesity, Inheritance of Acquired Characteristics | Bruce BlumbergM&M #124: Hormonal Contraception, Sex Hormones, Menstruation, Pregnancy, Puberty, Estrogens, Androgens, Effects of Birth Control on Cognition | Adriene Beltz*This content is never meant to serve as medical advice.Support the showAll episodes (audio & video), show notes, transcripts, and more at the M&M Substack Affiliates: MASA Chips—delicious tortilla chips made from organic corn and grass-fed beef tallow. No seed oils, artificial ingredients, etc. Use code MIND for 20% off. SiPhox Health—Affordable, at-home bloodwork w/ a comprehensive set of key health marker. Use code TRIKOMES for a 10% discount. Lumen device to optimize your metabolism for weight loss or athletic performance. Use code MIND for 10% off. Athletic Greens: Comprehensive & convenient daily nutrition. Free 1-year supply of vitamin D with purchase. Learn all the ways you can support my efforts

In this enlightening episode of Passion Struck, Johann Hari, acclaimed author of "Magic Pill," takes us on a deep dive into the extraordinary benefits and hidden risks of new weight loss drugs. Johann explores obesity not just as a personal struggle but as a profound societal issue intricately linked to our shift from whole foods to processed foods.These revolutionary drugs enhance satiety hormones, significantly aiding weight loss and reducing the risk of heart conditions. However, Johann also sheds light on the potential risks, including thyroid cancer and pancreatitis, and the complex impact these drugs can have on mental health by revealing underlying emotional eating patterns.Order a copy of my book, "Passion Struck: Twelve Powerful Principles to Unlock Your Purpose and Ignite Your Most Intentional Life," today!  Recognized as a 2024 must-read by the Next Big Idea Club, the book has won the Business Minds Best Book Award, the Eric Hoffer Award, the International Book Awards for Best Non-Fiction, the 2024 Melanie P. Smith Reader's Choice Contest by Connections eMagazine, and the Non-Fiction Book Awards Gold Medal. Don't miss the opportunity to transform your life with these powerful principles!Full show notes and resources can be found here:  https://passionstruck.com/johann-hari-truth-they-dont-tell-about-ozempic/In this episode, you will learn:The rise of obesity is linked to the transition from fresh, whole foods to processed or ultra-processed foodsNew weight loss drugs work by injecting an artificial copy of the hormone GLP-1, which helps regulate appetiteObesity is a significant risk factor for various health conditions, including heart disease, diabetes, and cancerWeight loss drugs like Ozempic can reduce the risk of heart attacks and strokes by 20%Potential risks of weight loss drugs include an increased risk of thyroid cancer and pancreatitisWeight loss drugs can disrupt eating patterns and bring underlying emotional drivers of eating to the surfaceAll things Johann Hari: https://johannhari.com/SponsorsBrought to you by Clariton, fast and powerful relief is just a quick trip away. Ask for Claritin-D at your local pharmacy counter. You don't even need a prescription! Go to “CLARITIN DOT COM” right now for a discount so you can Live Claritin Clear.--► For information about advertisers and promo codes, go to:https://passionstruck.com/deals/Catch More of Passion StruckWatch my solo episode on The 6 Key Steps to Bold Risk-Taking for Personal Growth.Can't miss my episode withMorley Robbins on How You Reclaim Your Health and VitalityListen to my interview withDr. Will Cole on how to restore your gut-feelings connectionCatch my interview with Dr. Kara Fitzgerald on How to Become a Younger You by Reversing Your Biological AgeListen to Seth Godin on Why We Need Systems Change to Save the PlanetLike this show? Please leave us a review here-- even one sentence helps! Consider including your Twitter or Instagram handle so we can thank you personally!